We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
Cap. Flow
+$149M
Cap. Flow %
2.07%
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$40.6M
2
ADSK icon
Autodesk
ADSK
+$38.8M
3
INTU icon
Intuit
INTU
+$37.1M
4
ECL icon
Ecolab
ECL
+$35.6M
5
KO icon
Coca-Cola
KO
+$35.1M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$51.9M
2
EOG icon
EOG Resources
EOG
+$33.8M
3
DATA
Tableau Software, Inc.
DATA
+$32M
4
MSFT icon
Microsoft
MSFT
+$29.8M
5
F icon
Ford
F
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 18.67%
2 Financials 17.68%
3 Consumer Discretionary 13.74%
4 Industrials 11.53%
5 Healthcare 11.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUI icon
826
Sun Communities
SUI
$15B
$276K ﹤0.01%
+2,150
New +$267K
ENT
827
DELISTED
Global Eagle Entertainment Inc.
ENT
$275K ﹤0.01%
16,946
+8,602
+103% +$155K
PCSB
828
DELISTED
PCSB Financial Corporation
PCSB
$271K ﹤0.01%
13,402
– –
DGICA icon
829
Donegal Group Class A
DGICA
$695M
$267K ﹤0.01%
17,513
+4,350
+33% +$61K
SURF
830
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$265K ﹤0.01%
94,100
+2,500
+3% +$9.95K
SHLO
831
DELISTED
Shiloh Industries Inc
SHLO
$265K ﹤0.01%
54,440
+12,765
+31% +$67.1K
AGYS icon
832
Agilysys
AGYS
$2.78B
$263K ﹤0.01%
12,250
-300
-2% -$6.22K
AL
833
DELISTED
Air Lease Corp
AL
$262K ﹤0.01%
6,330
-79,390
-93% -$3.03M
SCTL
834
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$261K ﹤0.01%
28,613
-35,905
-56% -$287K
IMGN
835
DELISTED
Immunogen Inc
IMGN
$261K ﹤0.01%
120,300
-168,840
-58% -$399K
FTK icon
836
Flotek Industries
FTK
$935M
$260K ﹤0.01%
13,100
– –
SRGA
837
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$258K ﹤0.01%
2,022
-2,571
-56% -$370K
CTRL
838
DELISTED
Control4 Corporation
CTRL
$258K ﹤0.01%
10,860
-43,169
-80% -$905K
NSA
839
DELISTED
National Storage Affiliates Trust
NSA
$257K ﹤0.01%
+8,880
New +$260K
HT
840
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$257K ﹤0.01%
15,517
-1,612
-9% -$28.6K
RGLD icon
841
Royal Gold
RGLD
$17.1B
$256K ﹤0.01%
+2,500
New +$225K
OPBK icon
842
OP Bancorp
OPBK
$233M
$254K ﹤0.01%
+23,435
New +$227K
AMRX icon
843
Amneal Pharmaceuticals
AMRX
$5.72B
$250K ﹤0.01%
+34,800
New +$356K
OTIC
844
DELISTED
Otonomy, Inc.
OTIC
$250K ﹤0.01%
90,798
-15,581
-15% -$41.5K
SKYW icon
845
Skywest
SKYW
$4.11B
$245K ﹤0.01%
4,030
– –
IESC icon
846
IES Holdings
IESC
$12.5B
$243K ﹤0.01%
12,889
– –
DNLI icon
847
Denali Therapeutics
DNLI
$3.67B
$242K ﹤0.01%
+11,660
New +$261K
ALV icon
848
Autoliv
ALV
$8.6B
$238K ﹤0.01%
+3,380
New +$247K
FF icon
849
Future Fuel
FF
$204M
$238K ﹤0.01%
+20,400
New +$254K
PRDO icon
850
Perdoceo Education
PRDO
$1.9B
$238K ﹤0.01%
12,500
– –
32 33
34
35 36

Similar funds

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $23.4B AUM
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Jacobs Levy Equity Management's Q2 2019 Portfolio in Review

As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
  • Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
  • Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
  • Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
  • Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
  • Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
  • Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.